Arthritis & Rheumatism, Volume 62,
November 2010 Abstract Supplement
Abstracts of the American College of
Rheumatology/Association of Rheumatology Health Professionals
Annual Scientific Meeting
Atlanta, Georgia November 6-11, 2010.
B Cell-Dependent Regulation (Breg) of T-Cell Proliferation Is Deficient in Systemic Lupus Erythematosus (SLE).
B Cells Induced Proteinuria and Glomerulopathy in Absence of Immune Complexes Similar to Minimal Change Disease.
B Cells Modify Regulatory T Cells in Healthy Individuals but Not in Patients with Systemic Lupus Erythematosus.
Bach1 Regulates Heme Oxygenase-1 Expression of Human Monocytes in Response to LPS: Implication in Behcet's Disease.
BAFF Binding Receptors (BBR) Related To Relapse after Rituximab in Patients with Reumatoid Arthritis (RA).
BAFF Expression Correlates with Idiopathic Inflammatory Myopathy Disease Activity Measures, Interferon Signature and Autoantibodies.
BAFF Expression on the Surface of RA Synovial Fibroblasts (RASFib) Facilitates B Cell Responses to IL-15.
Baseline ADAMTS5 Expression Could Sort the Prediction of Response to Infliximab or Adalimumab in Patients with Rheumatoid Arthritis.
Baseline Characteristics of Patients with Non-Infectious Mixed Cryoglobulinemia Vasculitis: Results from the French Nationwide CryoVas Survey.
Baseline Characteristics of Patients with Type I Monoclonal Cryoglobulinemia Vasculitis: Results from the French Nationwide CryoVas Survey.
Baseline CRP Predicts Early Improvement in Synovitis, Osteitis, and Erosion on MRI in RA Patients Treated with Tocilizumab: Results from the ACT-RAY MRI Substudy.
Baseline Differences in the Borderline Pulmonary Hypertension vs. Normal Hemodynamics: PHAROS Registry.
Baseline Factors Related to Response to Conventional DMARD Treatments.
Baseline Serum Interleukin-6 (IL-6), Tumor Necrosis Factor- (TNF-) and C-Reactive Protein (CRP) Do Not Predict Subsequent Hip Bone Loss in Men or Women: The Framingham Osteoporosis Study.
B-Cell Profiling Using Multi-Color Flow Cytometry as Biomarker of Disease Progression in Primary Sjogren's Syndrome (pSS).
Before Beginning Anti-TNF, a Better Targeted Screening and a Twice Decrease Frequency of Latent Tuberculosis (TB) with IFN gamma Release Assays (IGRA) Compared with Tuberculin Skin Test. Results in 396 Patients from the ETAT Study.
Behcet's Disease and the Major Histocompatibility Complex: Looking beyond HLA-B51.
Belimumab, a BLyS-Specific Inhibitor, Improved Fatigue and SF-36 Physical and Mental Component Summary Scores in Patients with SLE: BLISS-76 and -52 Studies.
Belimumab, a BLyS-Specific Inhibitor, Reduced Corticosteroid Use in Patients with Active SLE: Results from the Phase 3 BLISS-52 and -76 Studies.
Belimumab, a BLyS-Specific Inhibitor, Reduced Disease Activity across Multiple Organ Domains: Combined Efficacy Results from the Phase 3 BLISS-52 and -76 Studies.
Belimumab, a BLyS-Specific Inhibitor, Reduced Disease Activity and Severe Flares in Seropositive SLE Patients: BLISS-76 Study Results through Wk 76.
Belimumab, a BLyS-Specific Inhibitor, Reduced Disease Activity, Flares, and Prednisone Use in Patients with Seropositive SLE: Combined Efficacy Results from the Phase 3 BLISS-52 and -76 Studies.
Belimumab, a BLyS-Specific Inhibitor, Significantly Reduced Autoantibodies, Normalized Low Complement, and Reduced Selected B-Cell Populations in Patients with Seropositive Systemic Lupus Erythematosus (SLE): The Phase 3 BLISS Studies.
Bending the Cost Curve in Early RA: Sick Leave and Disability Pension before and after Initiation of Biologics or DMARD Combination Therapy.
Beneficial Effects of Systemic IFN Are Mediated by IL-1Ra: Implications for Rheumatoid Arthritis.
Benefit of Intra-Articular Corticosteroid Injections by Oral and Maxillofacial Surgery Treating Temporomandibular Joint Arthritis in Children with Juvenile Idiopathic Arthritis.
Best Scintigraphic Measures of Parotid Gland Dysfunction in Sjogren's Syndrome.
Better Results Are Achieved with Switching Directly to Biologics Than Switching Via DMARD Combinations in RA Patients Who Have Failed Methotrexate as Their Initial DMARD: Real Life Data from NOR-DMARD.
BILAG-Measured Improvement in Moderately and Severely Affected Body Systems in Patients with Systemic Lupus Erythematosus (SLE) by Epratuzumab: Results from EMBLEM, a Phase IIb Study.
Binding of Apoptotic Fetal Cardiocytes by Anti-Ro/La Antibodies Stimulates uPA/uPAR-Dependent Activation of TGFbeta and Potentiates Fibrosis.
Binding Target for C-Reactive Protein Is Released from Secondary Necrotic Cells.
Biochemical Markers of Bone Balance (CTX-I/Osteocalcin) Improve with Tocilizumab Treatment in a Population of RA Patients with an Inadequate Response to Anti-TNF Therapy.
Biologics and Risk of Lymphoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Biologics Use in SLE in 7 CentersData from the International Registry for Biologics in SLE (IRBIS).
Biomarkers for Global and Renal Disease Activity in Juvenile Systemic Lupus Erythematosus (jSLE).
Biomarkers of Oxidative Stress, mTOR Activation, and Treg Depletion Correlate with Disease Activity in Patients with Systemic Lupus Erythematosus.
Biomarkers Predictors of Good EULAR Response to B Cell Depletion Therapy (BCDT) in Seropositive Rheumatoid Arthritis Patients.
Bisphosphonate (BisP) Use May Be a Risk Factor for Osteonecrosis (ON) in Those Who Have Not Used Glucocorticoids (GCs): Data from the Health Improvement Network (THIN).
Blinded Multi-Rater Evaluation of Diagnosis and Candidate Classification Criteria for Polymyalgia Rheumatica (PMR). ACREULAR Study Group for Development of Classification Criteria for PMR.
BLK Confers a Risk for Renal Involvement in Japanese Patients with Systemic Lupus Erythematosus.
BLK Is Expressed in Human Peripheral T Cells and Thymocytes and Regulates CD4 T Cell Numbers in Cord Blood.
Blockade of CD40L with a Monovalent Fab' PEG Monoclonal Antibody Inhibits Disease in the Murine Collagen-Induced Arthritis Model.
Blockade of TLR2 Prevents Spontaneous and Induced Cytokine Release from Rheumatoid Arthritis Ex Vivo Synovial Explant Cultures.
Blockade of TNF or IL-1 Ameliorates Established C-Protein Induced Myositis of Mice.
BMS-582949 Is a Dual Action p38 Kinase Inhibitor Well Suited To Avoid Resistance Mechanisms That Increase p38 Activation in Cells.
Body Composition Trends in Patients with Rheumatoid Arthritis: Associations with Disease Characteristics and Inflammatory Markers.
Body Composition, Lower Extremity Strength, and Fatigue in SLE.
Body Weight and Response to Biologics in RA and Spondyloarthritides. Obesity Reduces the Rate of Remission-Response. The GISEA Registry.
Bone Density Following Long-Duration Spaceflight and Recovery.
Bone Density Measurement in Osteoarthritis Using Digital Radiographic Procedures.
Bone Events in Type 1 Gaucher Disease before and during Treatment.
Bone Geometry Parameters among Black and White Women with SLE.
Bone Marrow Lesion (BML) Size in Osteoarthritic Knees Correlates with Extent of Cartilage Damage and Predicts Longitudinal Cartilage Loss.
Bone Marrow Lesions (BMLs) Are Strongly Associated with Increased Bone Volume Fraction; Virtual Bone Biopsy Using MRI.
Bone Mineral Density and Body Composition in Systemic Sclerosis: A Case-Control Study.
Bone Remodeling in Postmenopausal Women Who Discontinued Denosumab Treatment.
Both Insulin Receptor and Nampt Activity Are Implicated in Visfatin/Nampt Induced PGE2 Synthesis in Articular Chondrocytes.
Brain Activity in Patients with Chronic Knee Pain Due to Osteoarthritis: Dissociating Evoked from Spontaneous Pain.
Breach of B Cell Tolerance in New Zealand Black Chromosome 1 Congenic Mice.
Bridging the Gap in Osteoporosis Care, Part I: Results of the SPOOF (Secondary Prevention of Osteoporotic Fracture) Project.